Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Asthma with Elevated Type 2 Biomarkers and Fixed Airflow Obstruction
Autor: | N.A. Hanania, M. Castro, E.D. Bateman, I.D. Pavord, A. Papi, J.M. FitzGerald, J.F. Maspero, C. Katelaris, D. Singh, N. Daizadeh, N. Pandit-Abid, B. Ortiz, E. Laws, J.A. Jacob-Nara, P.J. Rowe, Y. Deniz, D.J. Lederer, M. Hardin, S. Siddiqui |
---|---|
Rok vydání: | 2022 |
Zdroj: | C101. EXPANDING THE USE OF ASTHMA BIOLOGICS AND OTHER NOVEL THERAPEUTICS TO ADDITIONAL PATIENT POPULATIONS. |
DOI: | 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4843 |
Databáze: | OpenAIRE |
Externí odkaz: |